3rd Quarter - Report
REATA PHARMACEUTICALS for REATA PHARMACEUTICALS
Client
Income
—
Expenses
$65,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Burden of Chronic Kidney Disease
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL EGING | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.